SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-004983
Filing Date
2021-02-09
Accepted
2021-02-09 16:05:57
Documents
59
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20201231.htm   iXBRL 10-Q 2114309
2 EX-31.1 enta-ex311_8.htm EX-31.1 16044
3 EX-31.2 enta-ex312_7.htm EX-31.2 16030
4 EX-32.1 enta-ex321_6.htm EX-32.1 8775
5 GRAPHIC gobkflgva3gy000001.jpg GRAPHIC 182298
  Complete submission text file 0001564590-21-004983.txt   7528768

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20201231.xsd EX-101.SCH 33530
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20201231_cal.xml EX-101.CAL 44412
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20201231_def.xml EX-101.DEF 101060
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20201231_lab.xml EX-101.LAB 299116
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20201231_pre.xml EX-101.PRE 243050
11 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20201231_htm.xml XML 1451475
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 21606396
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences